Press releases
- BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
- BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
- BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
- BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
- BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
More ▼
Key statistics
On Tuesday, Bio-Techne Corp (TECH*:MEX) closed at 1,648.03, -31.86% above its 52-week low of 2,418.75, set on Jan 04, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | 1,100.00 |
Offer | -- |
Previous close | 1,098.24 |
Average volume | 0.00 |
---|---|
Shares outstanding | 157.19m |
Free float | 155.66m |
P/E (TTM) | -- |
Market cap | 11.88bn USD |
EPS (TTM) | -- |
Annual div (ADY) | 5.44 MXN |
---|---|
Annual div yield (ADY) | 0.49% |
Div ex-date | Feb 09 2024 |
Div pay-date | Feb 26 2024 |
Next div ex-date | May 10 2024 |
Next div pay-date | May 24 2024 |
Data delayed at least 20 minutes, as of Jan 04 2022 11:30 GMT.
More ▼